Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito
FrancoAngeli Journals

Newsletter "Clinica dell'Alcolismo"

N. 65-66 (2024)

Acamprosato: un ‘compagno’ di viaggio sicuro nella terapia alcol-correlata

DOI
https://doi.org/10.3280/mis65-66-2024oa18117
Inviata
11 luglio 2024
Pubblicato
31-07-2024

Riferimenti bibliografici

  1. (1) Anton R.F., O’Malley S.S., Ciraulo D.A., Cisler R.A., Couper D., Donovan D.M., Gastfriend D.R., Hosking J.D., Johnson B.A., LoCastro J.S., Longabaugh R., Mason B.J., Mattson M.E., Miller W.R., Pettinati H.M., Randall C.L., Swift R., Weiss R.D., Williams L.D., Zweben A. (2006). COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA, May 3, 295(17).
  2. (2) Burnette E.M., Nieto S.J., Grodin E.N., Meredith L.R., Hurley B., Miotto K., Gillis A.J., Ray L.A. (2022). Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs, Feb, 82(3): 251-274.
  3. (3) Guerzoni S., Pellesi L., Pini L.A., Caputo F. (2018). Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review. Pharmacol Res., Jul, 133: 65-76.
  4. (4) Epidemiologia e monitoraggio alcol-correlato in Italia - Rapporto 2020, Istituto Superiore di Sanità.
  5. (5) Jonas D.E., Amick H.R., Feltner C., Bobashev G., Thomas K., Wines R. et al. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, 311(18): 1889-900.
  6. (6) Kiefer F., Jahn H., Tarnaske T., Helwig H., Briken P., Holzbach R., Kämpf P., Stracke R., Baehr M., Naber D., Wiedemann K. (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry, Jan, 60(1): 92-9.
  7. (7) Maisel N.C., Blodgett J.C., Wilbourne P.L., Humphreys K., Finney J.W. (2013). Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?. Addiction, Feb, 108(2): 275-93.
  8. (8) McPheeters M., O’Connor E.A., Riley S., Kennedy S.M., Voisin C., Kuznacic K., Coffey C.P., Edlund M.D., Bobashev G., Jonas D.E. (2023). Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis. JAMA, Nov 7, 330(17): 1653-1665.
  9. (9) Rösner S., Hackl-Herrwerth A., Leucht S., Lehert P., Vecchi S., Soyka M. (2010). Acamprosate for alcohol dependence. Cochrane Database Syst Rev., (9), CD004332.

Metriche

Caricamento metriche ...